NASHVILLE, Tenn., Oct. 28, 2016 /CNW/ -- Cumberland Pharmaceuticals (NASDAQ: CPIX), based in Nashville, focused on specialty pharmaceuticals, today announced that A.J. Kazimi, Chief Executive Officer of Cumberland Pharmaceuticals, will present live at VirtualInvestorConferences.com on November 3, 2016.
DATE: Thursday, November 3, 2016
TIME: 11:30 AM ET
This will be a live, interactive online event where investors are invited to ask the company questions in real-time - both in the presentation hall as well as the association's "virtual trade booth." If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available for 90 days.
It is recommended that investors pre-register and run the online system check to save time and receive event updates.
Learn more about the event at www.VirtualInvestorConferences.com.
Recent Company Highlights
- In May 2016, acquired exclusive US rights to Ethyol®.
- In September 2016, announced a fourth development candidate in pipeline with Portaban™.
- Total net revenues during the first half of 2016 were $15 million resulting in adjusted earnings of $2 million or $.13 per share
- Over $90 million in total assets, including over $50 million in cash and marketable securities.
About Cumberland Pharmaceuticals
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops and commercializes branded prescription products designed to improve quality of care and address unmet medical needs.
With a focus on underserved niche markets, including hospital acute care and gastroenterology, we deliver products that serve patients in the U.S. market. Cumberland also makes its products available to patients internationally through select strategic partnerships.
While Cumberland's commercial capabilities are focused on the U.S. market, our business development team is actively pursuing opportunities to make our brands available to patients in markets around the globe.
Our primary mission is to improve upon patient care with products that offer clear advantages over existing treatments. We also strive to deliver solutions that may help reduce costs for healthcare providers and, ultimately, patients. For more information, visit our website at http://www.cumberlandpharma.com/
Since 2010, VirtualInvestorConferences.com, created by BetterInvesting (NAIC) and PRNewswire, has been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with investors using a graphically-enhanced online platform.
Designed to replicate the look and feel of location-based investor conferences, Virtual Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network.
SOURCE Cumberland Pharmaceuticals
For further information: Cumberland Pharmaceuticals, Erin Smith, Corporate Relations, +1.615.255.0068, [email protected]; VirtualInvestorConferences.com, Bradley H. Smith, Director of Marketing, IR and Compliance Services, PR Newswire, +1.201.947.7157, [email protected]